Propel Bio Management, LLC / MIRM
Propel Bio Management, LLC’s Mirum Pharmaceuticals Inc Position
Does Propel Bio Management, LLC own Mirum Pharmaceuticals Inc (MIRM)? Not currently — the last reported position was 70.0K shares worth $2M in Q1 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$2M
Q1 2024
Shares
70.0K
% of Portfolio
+1.02%
Quarters Held
2
position exited
Position History MIRM
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Propel Bio Management, LLC’s full portfolio or all institutional holders of MIRM.